Summary
GRI-related disorders are a group of rare genetic conditions that affect how the brain and nervous system work. They are caused by variations in genes that make proteins called ionotropic glutamate receptors. These receptors are important for learning, memory, and communication between brain cells. People with GRI-related disorders often have developmental delays, intellectual disability, seizures, movement problems, and other health issues. There is no cure, but treatments and therapies can help manage symptoms and improve quality of life.
Description
GRI-related disorders are caused by variations in genes such as GRIN, GRIA, GRIK, and GRID. These genes provide instructions for building NMDA (GRIN), AMPA (GRIA), kainite (GRIK), and delta (GRID) receptors, which help brain cells communicate. When these genes don’t work properly, the brain’s signals get mixed up, leading to problems with development, movement, and behavior. The disorders are named for the gene involved (for example, GRIN1, GRIN2A, GRIA2, GRIK2). Severity can range from mild learning problems to severe disabilities. Most cases happen by chance in only the person affected (de novo), but some can be inherited from a parent. Inherited variants can come from a mosaic parent – only some of the mother’s or father’s cells carry the variant – or mildly affected individuals.
Signs and Symptoms
Diagnosis is usually made with genetic testing and a review of symptoms. Common signs include:
- Developmental delay (late walking, talking, or learning)
- Intellectual disability (mild to severe)
- Seizures (epilepsy)
- Low or high muscle tone (hypotonia or hypertonia)
- Movement problems (dystonia, spasticity, repetitive movements)
- Speech difficulties or being nonverbal
- Autism or autism-like behaviors
- Feeding and swallowing problems
- Gastrointestinal issues (constipation, reflux)
- Vision problems (cortical visual impairment)
- Sleep disturbances
- Behavioral challenges (hyperactivity, outbursts or aggression)
Some children may have subtle symptoms at first, like mild delays or poor eye contact. Others may have more obvious problems, such as frequent seizures or trouble moving. Symptoms can change over time and may get better or worse as the child grows.
Causes
GRI-related disorders are caused by variations in genes that make ionotropic glutamate receptors. These variations usually happen randomly (de novo), but sometimes they can be inherited. The main genes involved are GRIN (for NMDA receptors), GRIA (for AMPA receptors), GRIK (for kainate receptors), and GRID (for delta receptors). There are no known environmental causes.
Laboratory Investigations
To diagnose GRI-related disorders, doctors may use:
Genetic testing
Whole exome sequencing or gene panels to find mutations in GRIN, GRIA, GRIK, or GRID genes. Sometimes children can have a missing piece of genetic material that includes a GRI gene (microdeletion) and is best detected on a different test called a chromosomal microarray. This can also be picked up on whole genome sequencing.
EEG
To check for abnormal brain activity and seizures.
MRI
To look for changes in brain structure.
Developmental assessments
To measure learning, speech, and motor skills. When children are older, this can also be referred to as Neuropsychologic testing.
These tests are usually done at diagnosis, but EEGs or MRIs may be repeated if new symptoms appear or to monitor progress.
Treatment and Therapies
There is no cure for GRI-related disorders, but treatment focuses on managing symptoms:
- Anti-seizure medications: To control epilepsy
- Physical, occupational, and speech therapy: To help with movement, daily skills, and communication
- Behavioral therapy: For autism or behavioral challenges
- Feeding support: For children with swallowing or nutrition problems
- Experimental treatments: Some drugs (like memantine or L-serine) are being studied for certain types of GRI disorders, but are not approved for these indications currently
Treatment plans are personalized for each person. Some medicines can cause side effects like tiredness or stomach upset. Without treatment, symptoms like seizures or developmental delays may get worse. Most people need lifelong support from a team of specialists.
Outlook
The outlook for people with GRI-related disorders depends on the type and severity of the gene change. Some children may learn to walk and talk with help, while others may need full-time care. Most will need support at school and at home. Independence as adults is rare for those with severe forms. The disorder affects daily life, school, and family routines. Diet and exercise do not cure GRI-related disorders, but a healthy lifestyle is important for overall well-being. Families often need to adjust routines and seek support from therapists, teachers, and community resources.
Resources
The CureGRIN Foundation’s mission is to improve the lives of individuals worldwide living with GRI Disorders (GRIA, GRID, GRIK, and GRIN) and their families. They achieve this through research, education, and support, working closely with scientists and the medical community to find treatments and cures. Their approach involves driving the research agenda, uniting and empowering the global GRI community, and strengthening operations, governance, and revenue.
The links and resources included in this section are solicited directly from the community by the Child Neurology Foundation through a formal submission process. CNF reserves the right to remove entities at any time if information is deemed inappropriate or inconsistent with the mission, vision, and values of CNF. The authors listed on this page have not endorsed the resources or links provided in this section.
Research
Currently, there are no listings for “GRI-Related Disorders” in ClinicalTrials.gov. Check back often and talk with your healthcare provider to identify upcoming trials.
If you have an interest in searching for any future trials that may be starting:
- Go to the Home page of ClinicalTrials.gov
- In the “Condition or disease” field, type “Disorder”. A drop-down list will appear if this disorder is included.
- You can narrow the search with the “Other terms”, “Intervention/Treatment”, and “Location” fields.
- Under “Study Status”, click on “Recruiting and not yet recruiting studies”.
- Click on “More Filters”, “Age”, “Child (birth – 17)”.
Family Stories
The information in the CNF Child Neurology Disorder Directory is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. CNF is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
References
1. T. A. Benke, K. Park, I. Krey, C. R. Camp, R. Song, A. J. Ramsey, et al. Clinical and therapeutic significance of genetic variation in the GRIN gene family encoding NMDARs. Neuropharmacology 2021 Pages 108805. PMID 34560056
https://www.ncbi.nlm.nih.gov/pubmed/34560056
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525401/pdf/nihms-1743869.pdf
2. W. XiangWei, Y. Jiang and H. Yuan . De Novo Mutations and Rare Variants Occurring in NMDA Receptors. Curr Opin Physiol 2018 Vol. 2 Pages 27-35. PMCID: PMC5945193 https://www.ncbi.nlm.nih.gov/pubmed/29756080
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945193/pdf/nihms934027.pdf
3. N. Julia-Palacios, M. Olivella, M. Sigatullina Bondarenko, S. Ibanez-Mico, B. Munoz-Cabello, O. Alonso-Luengo, et al. L-serine treatment in patients with GRIN-related encephalopathy: a phase 2A, non-randomized study. Brain 2024 Vol. 147 Issue 5 Pages 1653-1666. PMID: 38380699
https://www.ncbi.nlm.nih.gov/pubmed/38380699
https://academic.oup.com/brain/article-abstract/147/5/1653/7611854?redirectedFrom=fulltext
4. All About GRIN Disorder – CureGRIN Foundation [Internet]. [cited 2025 Jul 2]. Available from: https://curegrin.org/grin-disorder/
5. Perplexity AI, Inc. Perplexity [Internet]. San Francisco (CA): Perplexity AI, Inc.; 2025 [cited 2025 Oct 24]. Available from: https://www.perplexity.ai
This overview is for general information and is not a substitute for advice from your child's care team.
← Back to the Disorder Directory